# [BTG2]

## Mutation tier

|Entity|Tier|
|------|----|
|BL    |2   |
|DLBCL |1   |
|FL    |1   |

## Mutation incidence

|Entity|study                |frequency (%)|
|------|---------------------|-------------|
|BL    |GAMBL genomes+capture| 4.85        |
|BL    |Thomas cohort        | 4.20        |
|BL    |Panea cohort         | 9.90        |
|DLBCL |GAMBL genomes        |14.00        |
|DLBCL |Schmitz cohort       |17.20        |
|DLBCL |Reddy cohort         | 9.20        |
|DLBCL |Chapuy cohort        | 6.00        |
|FL    |GAMBL genomes        | 4.39        |

## Mutation pattern

|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
|------|----|---------------------|----------------|----------------|
|BL    |Yes |No                   |6.152           |42.280          |
|DLBCL |Yes |Yes                  |3.562           |10.265          |
|FL    |Yes |No                   |6.073           | 0.000          |

## aSHM regions

|chr_name|hg19_start|hg19_end |region|regulatory_comment|
|--------|----------|---------|------|------------------|
|chr1    |203274698 |203275778|intron|active_promoter   |

> [!NOTE]
> First described in BL in 2019 by [Panea RI](https://pubmed.ncbi.nlm.nih.gov/31558468). First described in DLBCL in 2011 by [Morin RD](https://pubmed.ncbi.nlm.nih.gov/21796119). First described in FL in 2011 by [Morin RD](https://pubmed.ncbi.nlm.nih.gov/21796119)